Drug Trial Radar · NCT07221357
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
990
Planned (sponsor's estimate)
Start
Dec 31, 2025
Primary completion
Feb 2, 2030
Study completion Mar 11, 2034
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- Collaborators
- BioNTech SE
- First posted
- Oct 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants with previously untreated, unresectable, or metastatic colorectal cancer
Conditions
- Untreated, Unresectable, or Metastatic Colorectal Cancer
Interventions
PumitamigDrug
Specified dose on specified days
FOLFOXDrug
Specified dose on specified days
FOLFIRIDrug
Specified dose on specified days
BevacizumabDrug
Specified dose on specified days
CAPOXDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response (OR) (confirmed complete response (CR) or partial response (PR)) by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 per investigator assessmentTime frame: Up to 5 years
- Progression Free Survival (PFS) by RECIST v1.1 per blinded independent central review (BICR)Time frame: Up to 5 years
- Overall Survival (OS)Time frame: Up to 5 years
Locations
286 sites in 25 countries. Site status is shown where the registry gives one.
Local Institution - 0428
Tucson, Arizona · Not yet recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
USC/Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Local Institution - 0330
Los Angeles, California · Withdrawn
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California · Recruiting
California Pacific Medical Center - Pacific Campus
San Francisco, California · Recruiting
Florida Cancer Specialists - East
Cape Coral, Florida · Recruiting
Florida Cancer Specialists - North
St. Petersburg, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Local Institution - 0326
Atlanta, Georgia · Not yet recruiting
Northside Hospital
Atlanta, Georgia · Recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
Local Institution - 0638
Fort Wayne, Indiana · Not yet recruiting
University of Iowa
Iowa City, Iowa · Recruiting
Local Institution - 0262
Baltimore, Maryland · Not yet recruiting
Maryland Oncology Hematology - Silver Spring
Silver Spring, Maryland · Recruiting
Local Institution - 0471
Boston, Massachusetts · Withdrawn
Local Institution - 0430
Ann Arbor, Michigan · Not yet recruiting
Local Institution - 0254
Grand Rapids, Michigan · Not yet recruiting
Minnesota Oncology
Maple Grove, Minnesota · Recruiting
Local Institution - 0318
Kansas City, Missouri · Not yet recruiting
Washington University School OF Medicine-Siteman Cancer Center
St Louis, Missouri · Recruiting
University Of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Northwell Health/ RJ Zuckerberg Cancer Center
Lake Success, New York · Recruiting
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Mineola, New York · Recruiting
New York Cancer and Blood Specialists
Shirley, New York · Recruiting
Local Institution - 0290
Charlotte, North Carolina · Not yet recruiting
Sanford Fargo Medical Center
Fargo, North Dakota · Recruiting
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
Lehigh Valley Health Network
Allentown, Pennsylvania · Recruiting
Local Institution - 0604
Pittsburgh, Pennsylvania · Not yet recruiting
Sanford Cancer Center
Sioux Falls, South Dakota · Recruiting
Local Institution - 0333
Nashville, Tennessee · Not yet recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Texas Oncology Dallas Fort Worth West (DFWW) - Arlington Cancer Center North
Arlington, Texas · Recruiting
Texas Oncology, PA
Austin, Texas · Recruiting
Baylor College of Medicine Medical Center
Houston, Texas · Recruiting
Texas Oncology - San Antonio
San Antonio, Texas · Recruiting
Local Institution - 0426
Salt Lake City, Utah · Not yet recruiting
Showing 40 of 286 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.